EGFR and ovarian carcinoma: In summary, our data demonstrated that the up‐regulation of FAM83D was involved in the progression of ovarian cancer and induced oncogenic events through activation of the EGFR pathway, promoted c‐Raf membrane localization and activated EGFR‐related downstream signal pathways which resulted in the proliferation and migration of cancer cells (Figure 5C).